trending Market Intelligence /marketintelligence/en/news-insights/trending/yikmorrik4eafzp1ov2wiw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Provention Bio appoints director

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Provention Bio appoints director

Provention Bio Inc. added Avery Catlin to its board.

Catlin was previously the senior vice president and CFO of Celldex Therapeutics Inc., a Hampton, N.J.-based biopharmaceutical company that develops immunotherapy technologies and other cancer-targeting biologics.

Oldwick, N.J.-based Provention Bio develops and commercializes novel therapeutics to treat and prevent immune-mediated diseases.